CAPRISA 004 microbicide trial
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:conductedBy |
gptkb:CAPRISA
|
| gptkbp:endDate |
2010
|
| gptkbp:fundedBy |
gptkb:CONRAD
gptkb:South_African_Department_of_Science_and_Technology gptkb:USAID |
| https://www.w3.org/2000/01/rdf-schema#label |
CAPRISA 004 microbicide trial
|
| gptkbp:location |
gptkb:KwaZulu-Natal,_South_Africa
|
| gptkbp:participants |
889
|
| gptkbp:principalInvestigator |
gptkb:Salim_Abdool_Karim
gptkb:Quarraisha_Abdool_Karim |
| gptkbp:publicationYear |
2010
|
| gptkbp:publishedIn |
gptkb:science
|
| gptkbp:result |
39% reduction in HIV acquisition
51% reduction in HSV-2 acquisition HIV infection prevention HSV-2 infection prevention |
| gptkbp:startYear |
2007
|
| gptkbp:studyType |
gptkb:clinical_trial
|
| gptkbp:targetAudience |
gptkb:women
|
| gptkbp:testedProduct |
gptkb:1%_tenofovir_gel
|
| gptkbp:bfsParent |
gptkb:Quarraisha_Abdool_Karim
|
| gptkbp:bfsLayer |
6
|